Cite
HARVARD Citation
Alten, R. et al. (2014). OP0152 Effects of Tofacitinib Monotherapy versus Methotrexate on Patient-Reported Outcomes in the 2-Year Phase 3 Oral Start TRIAL in Methotrexate-NaÏVe Patients with Rheumatoid Arthritis. Annals of the rheumatic diseases. pp. 118-119. [Online].